Invivyd to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025

Rhea-AI Summary

Invivyd (Nasdaq: IVVD) has announced its participation in the Oppenheimer 35th Annual Healthcare Life Sciences Conference. Marc Elia, Chairman of the Invivyd Board of Directors, will deliver a presentation on Wednesday, February 12th, 2025 at 1:20 PM ET.

The presentation will be accessible via live webcast through the investor section of Invivyd's website at investors.invivyd.com. The recording will remain available for approximately 90 days after the event.

News Market Reaction – IVVD

-23.04%

-23.04% Session move

In the trading session that priced this news, IVVD declined 23.04%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WALTHAM, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that Marc Elia, Chairman of the Invivyd Board of Directors, will be presenting at the Oppenheimer 35^th Annual Healthcare Life Sciences Conference.

The presentation is set to take place at 1:20 PM ET on Wednesday, February 12th. The live webcast link will be available in the investor section of the company's website at https://investors.invivyd.com and will be archived for approximately 90 days following the event.

About Invivyd
Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more.

Contacts:

Media Relations
(781) 208-1747
media@invivyd.com

Investor Relations
(781) 208-1747
investors@invivyd.com

FAQ

When is Invivyd (IVVD) presenting at the Oppenheimer Healthcare Conference 2025?

Invivyd (IVVD) is presenting at the Oppenheimer Healthcare Conference on Wednesday, February 12th, 2025, at 1:20 PM ET.

How can investors watch Invivyd's (IVVD) Oppenheimer Conference presentation?

Investors can watch the presentation through a live webcast available in the investor section of Invivyd's website at investors.invivyd.com.

How long will Invivyd's (IVVD) Oppenheimer Conference presentation be available for replay?

The presentation will be archived and available for approximately 90 days following the event on Invivyd's investor website.

Who is representing Invivyd (IVVD) at the 2025 Oppenheimer Healthcare Conference?

Marc Elia, Chairman of the Invivyd Board of Directors, will be presenting at the conference.